<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药渡 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-23T07:55:10+08:00</updated>
  <subtitle>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>一病一图 | 从全球首个丁肝新药Bulevirtide看丁肝的临床用药竞争格局</title>
    <updated>2021-01-22T18:14:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/ScuXKPJNO2vSjnlVmOQsxQ</id>
    <link href="https://mp.weixin.qq.com/s/ScuXKPJNO2vSjnlVmOQsxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年基因治疗领域面临的五大问题</title>
    <updated>2021-01-22T18:14:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/3VxA3MCn7gwhJYNDiEQYEw</id>
    <link href="https://mp.weixin.qq.com/s/3VxA3MCn7gwhJYNDiEQYEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【1月28日，线上直播】针对抗体偶联药物的分析能力及策略</title>
    <updated>2021-01-22T18:14:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/ckHMYwScH4t88LvPgOcWbA</id>
    <link href="https://mp.weixin.qq.com/s/ckHMYwScH4t88LvPgOcWbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>饶毅：正式举报裴钢院士学术不端</title>
    <updated>2021-01-22T18:14:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/RWsKi_oDEJQnvOfI908hoQ</id>
    <link href="https://mp.weixin.qq.com/s/RWsKi_oDEJQnvOfI908hoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十大单抗了解吗？点进来再看看吧</title>
    <updated>2021-01-22T18:14:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/t5_u8zpkwWyIjojzDL4ITw</id>
    <link href="https://mp.weixin.qq.com/s/t5_u8zpkwWyIjojzDL4ITw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 新媒体运营专员</title>
    <updated>2021-01-22T18:14:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/YG5XCYkypq0dwPVOfoTBEA</id>
    <link href="https://mp.weixin.qq.com/s/YG5XCYkypq0dwPVOfoTBEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点：国内在研的15款 T790M “EGFR-TKI”</title>
    <updated>2021-01-21T18:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/i_khIJNSYLcmpfO4Z_s_Cg</id>
    <link href="https://mp.weixin.qq.com/s/i_khIJNSYLcmpfO4Z_s_Cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>使抗体等大分子跨越血脑屏障的深耕者：Denali Therapeutics！</title>
    <updated>2021-01-21T18:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/JVPZdwbh4Ll90rTa7npx5w</id>
    <link href="https://mp.weixin.qq.com/s/JVPZdwbh4Ll90rTa7npx5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣获2021 BIG Innovation Award的IsoPlexis系统邀您共赴单细胞免疫组学分享会！</title>
    <updated>2021-01-21T18:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/Lh-NkJfA31LMD5YovbRz4Q</id>
    <link href="https://mp.weixin.qq.com/s/Lh-NkJfA31LMD5YovbRz4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【1月28日，线上直播】针对抗体偶联药物的分析能力及策略</title>
    <updated>2021-01-21T18:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/N1WsReBHZjvAzpM9fnN43g</id>
    <link href="https://mp.weixin.qq.com/s/N1WsReBHZjvAzpM9fnN43g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【1月27日 线上研讨会】全面解读：如何高效实施儿科临床研究</title>
    <updated>2021-01-21T18:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/YGkQ1iwi3QjC9IQgVRGvvQ</id>
    <link href="https://mp.weixin.qq.com/s/YGkQ1iwi3QjC9IQgVRGvvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 咨询合伙人</title>
    <updated>2021-01-21T18:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/2T_DB-PdW_LkPY1n-qUtXw</id>
    <link href="https://mp.weixin.qq.com/s/2T_DB-PdW_LkPY1n-qUtXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>类器官——疾病研究和药物开发的重要工具</title>
    <updated>2021-01-20T18:22:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/ZbARl7Kamag8qKwnSwNumw</id>
    <link href="https://mp.weixin.qq.com/s/ZbARl7Kamag8qKwnSwNumw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点 ：2018-2020国产1类新药上市图鉴</title>
    <updated>2021-01-20T18:22:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/CmHBsx2PtqNHrKcqexwGOQ</id>
    <link href="https://mp.weixin.qq.com/s/CmHBsx2PtqNHrKcqexwGOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【1月21号，线上直播】临床试验中的外部数据管理</title>
    <updated>2021-01-20T18:22:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/bJGMKG_li3x0d8S22yVKQA</id>
    <link href="https://mp.weixin.qq.com/s/bJGMKG_li3x0d8S22yVKQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 咨询师</title>
    <updated>2021-01-20T18:22:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/pBtai7OWLKuIvS833jvfOw</id>
    <link href="https://mp.weixin.qq.com/s/pBtai7OWLKuIvS833jvfOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>回顾：制药史首个百亿美元品种背后的专利战争！</title>
    <updated>2021-01-19T18:39:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/qINVgDRNx-bi5WeOaf-Vhg</id>
    <link href="https://mp.weixin.qq.com/s/qINVgDRNx-bi5WeOaf-Vhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【1月27日 线上研讨会】全面解读：如何高效实施儿科临床研究</title>
    <updated>2021-01-19T18:39:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/yftwkvHofempKyNC3-AgSA</id>
    <link href="https://mp.weixin.qq.com/s/yftwkvHofempKyNC3-AgSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【1月21号，线上直播】临床试验中的外部数据管理</title>
    <updated>2021-01-19T18:39:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/Ko3WL2dKQw6ekT4hNksHTg</id>
    <link href="https://mp.weixin.qq.com/s/Ko3WL2dKQw6ekT4hNksHTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>瑞德西韦去年卖出28亿美元，吉利德押中宝了吗？</title>
    <updated>2021-01-19T18:39:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/-A9BqQuyD0uCjDX6F7y2Sw</id>
    <link href="https://mp.weixin.qq.com/s/-A9BqQuyD0uCjDX6F7y2Sw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>